65º
    • News
    • Watch Live
    • Michigan COVID
    • Get Caught Up
    • Elections
    • Help Me Hank
    • Health
    • Local News
    • National
    • World
    • Community
    • Investigations
    • Entertainment
    • Environment
    • Politics
    • Flashpoint
    • Trust Index
    • Solutionaries
    • Meet The Team
    • Sports
    • Lions
    • Lions Stats
    • Tigers
    • Tigers Stats
    • Red Wings
    • Red Wings Stats
    • Pistons
    • Pistons Stats
    • Wolverines
    • Spartans
    • 4Frenzy
    • Bob Krause Golf
    • Features
    • Watch Local 4+
    • Parade
    • Vote 4 The Best
    • Click On Deals
    • Jobs 4 You
    • 4YI
    • All 4 Pets
    • Tech Time
    • Travel
    • Something Good
    • Mental Health Matters
    • StyleWise
    • Money Minute
    • Tasty Tuesday
    • Fitness Friday
    • Brag Book
    • Sunshine Awards
    • In The D
    • Food
    • TV Listings
    • MeTV Detroit
    • Contests
    • Live In The D
    • Dine In The D
    • Click On Deals
    • What's The Buzz
    • Uniquely Detroit
    • Events Live Guide
    • Ann Arbor
    • Headlines
    • Topics
    • Sports
    • Events
    • Ann Arbor Weather
    • Get Involved
    • Weather
    • Weather Center
    • Weather News
    • Alerts
    • StormPins
    • School Closings
    • Forecasting Change
    • 4ZONE - Metro
    • 4ZONE - North
    • 4ZONE - South
    • 4ZONE - West
    • Traffic
    • Road Construction Updates
    • Live Traffic Map
    • Newsletters
    • Contact Us
  • News
  • Sports
  • Features
  • Live In The D
  • Ann Arbor
  • Weather
  • Traffic
  • Newsletters
  • Contact Us
ClickOnDetroit.com
  • News
  • Sports
  • Features
  • Live In The D
  • Ann Arbor
  • Weather
  • Traffic
  • Newsletters
  • Contact Us
  • LIVE

Local 4 News at 7AM

Streaming on ClickOnDetroit and Local 4+ from 7 a.m. to 8 a.m. weekdays.

LIVE

Local 4 News at 7AM

Ad

JOHNSON & JOHNSON


Palm oil firms depriving tribes of millions of dollars

Companies supplying major manufacturers fail to meet promises to share land, joint BBC investigation finds.

bbc.co.uk

A major slide in this tech stock allows us to be buyers again

We're making a few trades in the portfolio Friday, selling a less favored name to buy higher quality stocks.

cnbc.com

We're selling half of a retail holding to get into an undervalued health care stock

The high grading of our portfolio continued Wednesday morning, with the moves made on American Eagle Outfitters and Johnson & Johnson.

cnbc.com

We're adding an appliance maker to our Bullpen as we look for new stocks to buy

After calling up a handful of names, we want to refresh a company already in our Bullpen, in addition to putting another one on it.

cnbc.com

YMCA Ann Arbor to host three COVID-19 vaccination clinics this week

Free COVID-19 vaccinations will be available at three vaccine clinics at Ann Arbor YMCA’s downtown location, 400 W. Washington St., this week.

Idaho announces $119 million opioid crisis settlement

Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.

npr.org

J&J names Thibaut Mongon, current consumer health leader, as CEO of new spin-off company

J&J announced in November that it would sheer off the consumer health business from its faster-growing medical devices and pharmaceutical portfolios.

cnbc.com

Baltimore vaccine maker hid potential problem, House report says

Cross-contamination of coronavirus vaccines being made for Johnson & Johnson and AstraZeneca was discovered in March 2021. The company had more than $1.3 billion worth of contracts from the federal government and from Johnson & Johnson and AstraZeneca to make the vaccines. The hold tags indicated a potential quality problem with the vaccine in the containers, the House panel found. After discovery of cross-contamination, the Biden administration suspended the plant’s production of the Johnson & Johnson vaccine in April and permanently halted production of the AstraZeneca vaccine at the plant. But even after the restart in August, problems continued, according to the House report.

washingtonpost.com

Regulators limit use of J&J COVID vaccine, citing rare blood clots

Federal regulators are limiting the use of Johnson & Johnson’s COVID-19 vaccine to cases where mRNA vaccines aren’t an option. An exception will be made if an adult elects to receive the J&J shot and would otherwise not receive a COVID-19 vaccine. After further review by the CDC’s advisory committee, and time for physicians to learn how to treat the condition, regulators allowed use of the Johnson & Johnson vaccine to resume. Among them, 393,366 residents received a Johnson & Johnson shot, including only 10,221 since Jan. 1. Spring surge pushes beyond metro Detroit: Michigan COVID data for Thursday, May 5Fire Watch issued for parts of Michigan with warm, dry weekend ahead

mlive.com
Ad

Judge Lets Tulsa Race Massacre Reparations Lawsuit Proceed

The suit seeks punitive damages, calls for a hospital, mental health and education programs, as well as a Tulsa Massacre Victims Compensation Fund.

newsy.com

Stocks making the biggest moves midday: Twitter, Johnson & Johnson, WeWork and more

These are the stocks posting the largest moves in midday trading.

cnbc.com

J&J suspends COVID-19 vaccine sales forecast

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.

J&J lowers 2022 revenue and earnings expectations, stops giving Covid vaccine sales guidance

Johnson & Johnson on Tuesday lowered its full-year sales and earnings outlook, and stopped providing Covid-19 vaccine sales guidance due to a global supply surplus and demand uncertainty. J&J is now forecasting 2022 sales of $94.8 billion to $95.8 billion, about one billion dollars lower than the guidance provided in January. J&J reported first-quarter sales of $23.4 billion, slightly missing Wall Street expectations but growing 5% over the same quarter last year. The company's medical devices business grew by 5.9% to $6.97 billion in sales compared to the first quarter of 2021. "Looking ahead, I remain confident in the future of Johnson & Johnson as we continue advancing our portfolio and innovative pipeline."

cnbc.com

Stock futures nudge higher ahead of busy earnings day

Stock futures moved higher early Tuesday morning after stocks slipped during regular trading hours on Monday.

cnbc.com

J&J's Janssen settles with WVa for $99M in opioid lawsuit

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths.

Johnson & Johnson Ordered To Pay $302M In Pelvic Mesh Case

An appeals court judge found that the company made misleading and potentially harmful statements in advertisements and instructional brochures.

newsy.com

Johnson & Johnson ordered to pay $302M in pelvic mesh case

A California appeals court has upheld a lower court ruling that Johnson & Johnson must pay $302 million in penalties to the state for deceptively marketing pelvic mesh implants for women.

Michigan considers how to spend $776 million in opioid settlement money

Michigan is set to receive $776 million from three opioid distributors and an opioid manufacturer, as part of a $26 billion nationwide settlement for their role in the opioid epidemic. The money comes from pharmaceutical distributors Cardinal, McKesson and AmerisourceBergen as well as opioid manufacturer Johnson & Johnson. It’s one of the largest multi-state agreement in U.S. history, second only to the tobacco settlement of 1998. Nessel said the payout could top $1 billion once Purdue Pharma’s still-pending settlement money is added to the pot. RELATED STORIESNew vending machine at Ann Arbor library offers free kits to stop opioid overdosesOne of Michigan’s top payouts from national opioid lawsuits settlement could come to Washtenaw CountyGenesee County to receive nearly $16M from historic opioid settlement

mlive.com
Ad

EXPLAINER: Where do US opioid trials, settlements stand?

A trial on whether pharmacy chain Walgreens bears responsibility for the opioid crisis started Monday in Florida on the heels of opening statements last week in another opioid trial in West Virginia.

WVa trial expert: Drug makers downplayed risks in marketing

Lawyers for the state of West Virginia are concluding the first week of a trial against three major opioid makers.

Ann Arbor YMCA hosting COVID-19 vaccination clinics this month

Three upcoming vaccine clinics at the Ann Arbor YMCA are free and open to the public.

Rich companies are using a quiet tactic to block lawsuits: bankruptcy

Companies that aren't bankrupt are using controversial maneuvers in U.S. bankruptcy court to block tens of thousands of suits. A woman suing Johnson & Johnson died while her case was in legal limbo.

npr.org

Next decade will transform health care more than past century: Johnson & Johnson CEO

Johnson & Johnson's new CEO Joaquin Duato says in his first interview that AI in medicine will lead to innovations including real-time surgery decisions.

cnbc.com

Michigan AG: Monroe County to receive $6M from opioid lawsuits

Monroe County will soon see some money from a roughly $26 billion national opioid settlement that was finalized last month.

monroenews.com

Unable to sue, Michigan woman files claim in her mom’s COVID-19 vaccine-related death

Tatum Strieter-Byron is asking the federal government to compensate her for her mother Sandra Jacobs’ death in April of a confirmed complication of the Johnson & Johnson COVID-19 vaccine. It was established because COVID-19 vaccine manufacturers and others are granted liability protections through the Public Readiness Emergency Preparedness Act, enacted in 2005. In 2020, the U.S. Health and Human Services secretary invoked the act and declared COVID-19 a public health emergency, warranting Johnson & Johnson and others immunity from lawsuits. About 18.5 million Johnson & Johnson doses have been administered in the United States, making the side-effect rare. The CDC now recommends the Pfizer and Moderna vaccines over the Johnson & Johnson vaccine because of the risk of serious adverse events.

mlive.com

J&J and other opioid players to pay $26 billion to states over roles in addiction crisis

"It's not enough, but it's a good start," one lawyer said of settlement to fund local treatment and education efforts.

cbsnews.com

Johnson & Johnson wins a key court battle in baby powder case

A federal judge has allowed a Johnson & Johnson spinoff to proceed with a controversial bankruptcy, despite complaints from thousands who say they were harmed by the company's baby powder.

npr.org
Ad

4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis

The companies, including Johnson & Johnson and McKesson, will admit no wrongdoing. Billions of dollars in payouts will fund drug treatment and harm reduction programs.

npr.org

J&J, distributors finalize $26B landmark opioid settlement

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the opioid addiction crisis.

Sure and Brut deodorant sprays recalled nationwide after benzene detected

Analysis finds "unexpected levels" of human carcinogen coming from propellant that sprays product out of the can.

cbsnews.com

Moderna, Pfizer stocks fall as omicron Covid wave subsides in U.S.

Moderna dropped more than 12%, the biggest decline in the S&P 500 as of Monday afternoon.

cnbc.com

Johnson & Johnson halts production of single-dose COVID-19 vaccine, report says

Drugmaker reportedly closed the Dutch plant that was making the vaccine in order to focus on a different drug.

cbsnews.com

Johnson & Johnson halts production of single-dose COVID-19 vaccine, report says

Drugmaker reportedly closed the Dutch plant that was making the vaccine in order to focus on a different drug.

cbsnews.com

Johnson & Johnson plant pauses Covid vaccine production, report says

The only Johnson & Johnson facility making usable batches of the company's Covid vaccine has temporarily halted its production, The New York Times reported.

cnbc.com

Tribes: Settlement in opioids case will foster healing

Money that will flow to Native American tribes as part of an opioid drug settlement with a major manufacturer and three distributors won't come quickly.

Native American Tribes Reach $590 Million Opioid Settlement

All federally recognized tribes in the U.S. will be able to participate in the settlements, even if they did not sue over opioids.

newsy.com
Ad

Native American tribes reach a tentative opioid settlement with J&J and distributors

Johnson & Johnson, AmerisourceBergen, McKesson and Cardinal Health will pay $590 million to Native American tribes under a proposed settlement for the companies' role in the opioid crisis.

npr.org

Johnson & Johnson, drug distributors to pay tribes $590 million in opioid deal

Landmark legal settlement offers "measure of justice" to Native American communities hit by opioid epidemic.

cbsnews.com

Native American tribes reach $590 million opioid settlement

Native American tribes have reached opioid settlements worth over a half-billion dollars with drugmaker Johnson & Johnson and three distributors.

Czechs hit virus record but see significantly fewer deaths

The Czech Republic has recorded a significant decline in people dying of COVID-19 despite facing a record number of infected in one month.

FDA fully approves the Moderna COVID-19 vaccine for adults

The U.S. Food and Drug Administration on Monday, Jan. 31, fully approved the Moderna COVID-19 vaccine. Updated analyses to determine the effectiveness of the Moderna vaccine included 14,287 vaccine recipients and 14,164 placebo recipients 18 and older who did not have evidence of coronavirus infection before receiving their first dose. The Moderna vaccine is the second most commonly administered vaccine in Michigan. Fewer than 400,000 people received the Johnson & Johnson and about 43,000 got the booster. The Pfizer and Moderna mRNA vaccines are preferred to the Johnson & Johnson vaccine, linked to deaths from a rare, but serious blood clotting disorder.

mlive.com

Danes halt virus restrictions; rest of Europe a patchwork

Denmark is scraping most pandemic restrictions as the country no longer considers COVID-19 to be “a socially critical disease.”.

Novavax could offer unvaccinated Americans a new option, if regulators agree

Novavax's shots are based on a kind of "protein subunit" technology that has been used for decades in other routine vaccinations.

cbsnews.com

Novavax could offer unvaccinated Americans a new option, if regulators agree

Novavax's shots are based on a kind of "protein subunit" technology that has been used for decades in other routine vaccinations.

cbsnews.com

Stocks making the biggest moves in the premarket: 3M, Johnson & Johnson, General Electric and more

The stocks making the biggest moves in premarket trading include 3M, Johnson & Johnson, General Electric and more.

cnbc.com
Ad

J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report

Johnson & Johnson on Tuesday projected that its Covid vaccine would generate $3 billion to $3.5 billion in sales in 2022, after posting a mixed fourth-quarter report that slightly beat on earnings' estimates but missed on revenue. Revenue: $24.8 billion, vs. $25.29 billion expectedCFO Joseph Wolk told CNBC a strengthening dollar negatively impacted top line sales by $150 million to $200 million. Hospital staffing shortages caused by the omicron Covid variant also generated uncertainty in the company's medical devices business, particularly with elective procedures, Wolk said. J&J reported $93.77 billion in sales in 2021, a 13.6% increase over the prior year. J&J said it expects to generate $10.40 to $10.60 in earnings per share this year and $98.9 billion to $100.4 billion in revenue.

cnbc.com

Prescription drugs, medical devices boost J&J in Q4

Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the health care giant’s COVID-19 vaccine gained momentum as well.

Ron Johnson says mouthwash can kill COVID-19. Manufacturer of Listerine, medical experts say there's no evidence yet to prove that.

The Wisconsin senator said a "standard gargle" of mouthwash "has been proven to kill the coronavirus" or may reduce viral replication.

news.yahoo.com

Johnson & Johnson is spinning off its consumer division, which could come with risks

Wall Street analysts say Johnson & Johnson's decision to spin off its consumer division is overall a smart business move but it could come with some risks.

cnbc.com

Eastern Michigan University to host walk in COVID-19 vaccination clinic Saturday

The clinic will be held in Ballroom A of the EMU Student Center between 10 a.m. to 4 p.m.

Get vaccinated against COVID-19 at Cahoots in Ann Arbor on Thursday

Cahoots will be offering a walk-in COVID vaccine clinic on Thursday.

New COVID studies show promise for the Johnson & Johnson vaccine booster

Two studies that have not yet been peer reviewed indicate increased protection against the infectious omicron variant.

npr.org

Marjorie Taylor Greene, who has boasted about being unvaccinated, owns stock in 3 major vaccine makers

Insider's Conflicted Congress project revealed Greene holds AstraZeneca, Pfizer, and Johnson & Johnson stock, each worth between $1,000 and $15,000.

news.yahoo.com

P&G shampoo recall is only the latest for benzene in spray products

More than half a dozen recalls have been issued this year as carcinogen is also found in sunscreens, foot deodorants.

cbsnews.com
Ad

Oregon, among last holdout states, to join opioid agreement

Oregon is on the verge of signing onto a $26 billion settlement with the three largest distributors of opioids and drugmaker Johnson & Johnson after being one of the latest holdout states to join.

South Africa's president back to work after COVID isolation

South African President Cyril Ramaphosa has returned to work following a week of isolation after testing positive for COVID-19

washingtonpost.com

Stocks making the biggest moves midday: FedEx, Oracle, Johnson & Johnson and more

These are the stocks posting the largest moves in midday trading.

cnbc.com

Omicron variant reported in 38 states as COVID cases across the country increase

Though reported Omicron cases have so far been mild, experts advise that every precaution should be taken to prevent infection.

cbsnews.com

CDC endorses Pfizer, Moderna COVID-19 vaccines over Johnson & Johnson

Individuals unable or unwilling to receive an mRNA vaccine will continue to have access to the Johnson & Johnson vaccine, approved in February for American adults, the CDC reported. There is not an increased risk of the disorder after doses of the Pfizer and Moderna vaccines, according to the CDC. In April, the Johnson & Johnson vaccine brought about the death of a Michigan woman, 60-year-old Sandra Jacobs of Saline. Johnson & Johnson is the least commonly administered of the three vaccines. In April, when distribution of the Johnson & Johnson vaccine resumed after a pause to explore the reports of TTS, it was said to be 90% effective against hospitalization.

mlive.com

Advisory committee recommending Pfizer, Moderna vaccines over J&J vaccine, linked to 9 deaths

A federal vaccine advisory committee is now recommending the Pfizer and Moderna vaccines over the Johnson & Johnson vaccine, linked to rare but serious blood clotting disorder, according to the Associated Press. In April, the Johnson & Johnson vaccine brought about the death of a Michigan woman, 60-year-old Sandra Jacobs of Saline. RELATED: Michigan woman’s death caused by rare Johnson & Johnson COVID vaccine side effect, autopsy report saysJust five days earlier, federal health agencies temporarily paused the vaccine administration while they examined the vaccine and TTS. Federal heath authorities already have said that those receiving the Johnson & Johnson vaccine could get a Moderna or Pfizer booster shot. Early data indicated a dose of mRNA vaccine after the Johnson & Johnson vaccine would be better than a second dose of the Johnson & Johnson shot, providing a greater rise in antibodies.

mlive.com

CDC reports heart inflammation cases among young kids who got Pfizer COVID-19 shot

The U.S. Centers for Disease Control and Prevention said on Thursday it had received reports of eight cases of myocarditis, a type of heart inflammation, in children aged 5-11 years who received Pfizer and BioNTech's COVID-19 vaccine.

news.yahoo.com

CDC expert panel prefers Pfizer, Moderna vaccines over J&J shots for adults due to rare blood clot cases

The Advisory Committee on Immunization Practices voted unanimously to recommend Pfizer and Moderna over the Johnson & Johnson vaccine. Seventeen men developed TTS. A week later, the FDA and the CDC lifted the pause on J&J shots after the independent advisory panel said the benefits of the shots outweighed the risks. In October, the FDA and CDC authorized J&J boosters for all adults at least two months after receiving their initial J&J shot. People who received their primary vaccination with the J&J shot can also get boosted with the Pfizer or Moderna vaccines.

cnbc.com

CDC recommends Pfizer, Moderna COVID-19 shots over J&J's

U.S. health officials say most Americans should get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot.

Ad

EU regulators: J&J vaccine booster OK to give after 2 months

The European Union drugs regulator says people 18 and older can receive a booster shot for the Johnson & Johnson COVID-19 vaccine at least two months after their initial shot of the one-dose vaccine.

Supreme Court rejects Johnson & Johnson request to halt talcum powder suit

Mississippi alleges the consumer products giant failed to warn users of "potentially lethal" health risks.

cbsnews.com

University of Michigan issues COVID safety guidance to school community ahead of winter break

U-M officials issue guidance to school community ahead of holiday travel.

High court won't hear Mississippi lawsuit over talcum powder

The Supreme Court has turned away a request by Johnson & Johnson to halt a Mississippi lawsuit over its talcum powder products.

Covax promised 2 billion vaccine doses to help the world’s neediest in 2021. It won’t even deliver even half that.

The U.N.-led initiative is now aiming for 800 million doses to be delivered by the end of the year, but that isn't assured.

washingtonpost.com

Ron Johnson says mouthwash can kill COVID-19. Manufacturer of Listerine, medical experts say there's no evidence yet to prove that.

Johnson said a "standard gargle" of mouthwash "has been proven to kill the coronavirus" or may reduce viral replication.

news.yahoo.com

CEOs and scientists on whether existing vaccines will work against Omicron

Moderna president said current COVID-19 vaccines probably aren't effective against the new variant.

cbsnews.com

COVID breakthrough cases after boosters? Is there a Johnson & Johnson booster?

Since the coronavirus pandemic began, Dr. Frank McGeorge has been keeping viewers up-to-date and informed on all fronts.

Washington seeks over $38 billion from opioid distributors

Washington Attorney General Bob Ferguson has taken the state’s case against the nation’s three biggest drug distributors to trial.

Ad

Johnson & Johnson to split into 2, aim for faster growth

Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine from its medical device and prescription drug business.

All Czech students to be tested to curb surge in virus cases

The Czech government is requiring children to get tested for COVID-19 as part of efforts to curtail a recent steep rise in cases.

Oklahoma court overturns $465M opioid ruling against J&J

The Oklahoma Supreme Court has overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state’s public nuisance law.

NBA to players, coaches, refs: Booster shots are recommended

The NBA has told its players, coaches and referees that they should receive booster shots against the coronavirus, with particular urgency for those who received the single-dose Johnson & Johnson vaccine.

Report: US cancels vaccine maker’s multimillion dollar deal

The federal government has canceled a multimillion dollar deal with Emergent BioSolutions, a Maryland- based vaccine manufacturer with facilities in Baltimore that were found to have produced millions of contaminated vaccine doses this spring.

Tracking Michigan COVID vaccine coverage

Here we are tracking Michigan’s COVID-19 vaccine coverage.

Drug companies win in California opioid crisis lawsuit

Top drug manufacturers have won a round in a California lawsuit that blamed them for the opioid crisis and sought billions of dollars to cover the costs of dealing with it.

California judge rules for opioid makers in damages lawsuit

A California judge has ruled for top drug manufacturers as local governments seek billions of dollars to cover their costs from the nation’s opioid epidemic.

FDA sets stronger safety warnings for breast implants

The Food and Drug Administration is enforcing new warnings on breast implants.

Ad

Washtenaw County Health Department to start offering Moderna, Johnson & Johnson booster shots

The boosters will be available at October drive-through clinics and ongoing walk-in clinics by the Washtenaw County Health Department.

Michigan health officials urge COVID vaccine booster doses for those eligible: Here’s what to know

Michiganders who are eligible to receive a COVID-19 vaccine booster dose are urged to do so now.

Washtenaw County woman’s death attributed to rare complication from Johnson & Johnson vaccine, report says

While vaccines have been overwhelmingly successful at protecting people from contracting the virus, in rare cases, there have been documented illnesses and even deaths.

Michigan health officials urge J&J, Moderna COVID vaccine booster doses for those eligible: Here’s what to know

Michiganders who are eligible to receive a COVID-19 vaccine booster dose from Johnson & Johnson or Moderna are urged to do so now.

COVID vaccine: CDC expands booster rollout, OKs mixing shots

Federal health officials say millions more Americans can get a COVID-19 booster and choose a different vaccine for that next shot.

Asian stocks mixed after Wall Street rises for 5th day

Asian stock markets are higher after Wall Street rose for a fifth day on strong corporate earnings.

US expected to authorize mix-and-match COVID booster shots

Federal regulators are expected to authorize the mixing and matching of COVID-19 booster shots this week.

Reports: FDA expected to OK ‘mix-and-match’ COVID vaccine boosters

The Food and Drug Administration is expected to announce this week people will be able to receive a COVID-19 vaccine booster shot with a vaccine from a different manufacturer than their original doses, according to reports in the New York Times, Washington Post and Wall Street Journal.

J&J hikes 2021 profit forecast, COVID-19 vaccine sales grow

Sales of the cancer treatment Darzalex helped Johnson & Johnson deliver better-than-expected third quarter earnings, while COVID-19 fueled vaccine revenue and had more customers reaching for Tylenol.

Ad

Michigan business groups urge Biden to reconsider vaccine, testing mandate

Michigan business groups are urging President Joe Biden to reconsider a plan to require most workers to get vaccinated or regularly tested for COVID-19 but say, if it is enacted, Gov. Gretchen Whitmer should ensure related state rules are no stricter.

FDA advisory committee votes to approve Johnson & Johnson vaccine booster shots

The outside panel of experts voted unanimously in favor of offering booster doses of the Johnson & Johnson vaccine at least two months after the first dose.

Cities, police unions clash as vaccine mandates take effect

Police departments that are requiring officers to be vaccinated against COVID-19 are running up against pockets of resistance across the U.S. Police unions and officers are pushing back by filing lawsuits to block the mandates.

FDA panel endorses booster shot for J&J COVID-19 vaccine

A panel of U.S. health advisers has endorsed booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine.

FDA advisory committee votes to approve Moderna vaccine booster shots for vulnerable groups

The outside panel of experts voted unanimously in favor of offering Moderna boosters to specific groups of people, at least six months after their second dose.

Live stream: FDA advisory panel meets over Moderna, Johnson & Johnson COVID vaccine booster shots

The Food and Drug Administration’s (FDA) vaccine advisory panel is set to meet Thursday and Friday, Oct. 14-15, over Moderna and Johnson & Johnson booster shots.

FDA grapples with timing of booster for J&J COVID-19 vaccine

The Food and Drug Administration is wrestling with how to decide on booster doses of the single-shot Johnson & Johnson COVID-19 vaccine.

FDA advisory panel to meet on Moderna, Johnson & Johnson COVID vaccine booster shots

The Food and Drug Administration’s vaccine advisory panel is set to meet Thursday and Friday, Oct. 14-15, and we are getting our first look at the data the panel will be using to make its recommendation on booster shots for Moderna and Johnson & Johnson.

The Latest: Manufacturer recalling some at-home test kits

COVID-19 test kit maker Ellume is recalling some at-home tests after learning that they were reporting a higher-than-expected rate of false positive results.

J&J seeks US clearance for COVID-19 vaccine booster doses

Johnson & Johnson has asked U.S. regulators to allow booster shots of its COVID-19 vaccine as the U.S. government moves toward shoring up protection in more vaccinated Americans.

  • TV Listings
  • Contests and Rules
  • Email Newsletters
  • RSS Feeds
  • Closed Captioning
  • Contact Us
  • Careers at WDIV
  • Terms of Use
  • Privacy Policy
  • Public File
  • FCC Applications
  • Do Not Sell My Info
Follow Us
facebook
twitter
instagram
snapchat
rss
Get Results with Omne
Omne Results Logo

If you need help with the Public File, call (313) 222-0566.


Graham Media Group LogoGraham Digital Logo

Copyright © 2022 ClickOnDetroit.com is managed by Graham Digital and pubished by Graham Media Group, a division of Graham Holdings.